Chylarecki C, Hierholzer G, Rudofsky G
Berufsgenossenschaftliche Unfallklinik, Duisburg-Buchholz.
Unfallchirurgie. 1995 Jun;21(3):137-47. doi: 10.1007/BF02589951.
Between 1993 and 1994 the value of the "Artroflow" device in deep venous thrombosis was tested in 95 trauma surgical high risk patients. Parallel to the application of Heparin and physical methods, the "Artroflow" device was employed. The test and compare group showed an equal amount of risk parameters and comparable injuries. In all patients until full mobilization a weekly clinical examination, a compression sonography of the deep leg veins and a venous Doppler examination was performed. In the test group 1 deep venous thrombosis (2.3%) and no clinically manifest lung embolism occurred. In the control group, the deep venous thrombosis rate was 21.6%. This showed a highly significant drop of the deep venous thrombosis rate in trauma surgical patients (p < 0.0041 Fisher test) and allows us to suggest the use of the "Artroflow" device in high risk patients parallel to heparin prophylaxis.
1993年至1994年间，在95例创伤外科高危患者中测试了“Artroflow”装置在深静脉血栓形成中的价值。在应用肝素和物理方法的同时，使用了“Artroflow”装置。试验组和对照组的风险参数数量相等，损伤情况相当。在所有患者完全活动之前，每周进行一次临床检查、下肢深静脉压迫超声检查和静脉多普勒检查。试验组1出现1例深静脉血栓形成（2.3%），未发生临床明显的肺栓塞。对照组的深静脉血栓形成率为21.6%。这表明创伤外科患者的深静脉血栓形成率显著下降（Fisher检验，p < 0.0041），这使我们建议在肝素预防的同时，对高危患者使用“Artroflow”装置。
